I have not had a chance to read it yet, but the US State Department has released a public version of the award in the investment treaty claim Apotex v United States. The claim concerned an import alert issued by the Food and Drug Administration with respect to products manufactured by Apotex in Canada.
Investment Arbitration Reporter has some initial coverage of the award (behind a paywall). I plan to take a good look at the award in the coming weeks. In the meantime, I would merely note that the Apotex claim joins the recent Achmea claim noted here, that also failed. These are just two of a number of recent claims concerning health issues.